MicroRNA-495 regulates human gastric cancer cell apoptosis and migration through Akt and mTOR signaling

被引:14
作者
Wang, Jun [1 ]
Feng, Weiwei [2 ]
Dong, Yuanqiang [1 ]
Mao, Xiang [1 ]
Guo, Fenghua [1 ]
Luo, Fen [1 ]
机构
[1] Fudan Univ, Huashan Hosp, 12 Urumqi Rd, Shanghai 200040, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, China Welf Inst, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China
关键词
microRNA-495; human gastric cancer; autophagy; PI3K; Akt; caspase-3; -9; cyclin D1; NF-KAPPA-B; ULCERATIVE-COLITIS; INDUCTION THERAPY; OXIDATIVE STRESS; MYRICETIN; PATHWAY; SUPPRESSION; DISEASE;
D O I
10.3892/or.2018.6722
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study, we investigated the expression and cellular distribution of microRNA-495 (miR-495) in human gastric cancer. Prominent downregulation of miR-495 activation was evident in patients with gastric cancer. Cell viability and Annexin V/PI apoptosis assays were used to assess cell proliferation and apoptosis. Then, western blot analysis was used to assess cyclin D1, PI3K, p-Akt and p-mTOR protein expression. Overexpression of miR-495 significantly inhibited cell proliferation, and promoted cell apoptosis of gastric cancer cells. Overexpression of miR-495 also promoted caspase-3/-9 and Bax protein expression, and suppressed cyclin D1 protein expression and the PI3K/Akt/mTOR pathway in gastric cancer cells. Downregulation of miR-495 increased cell proliferation and inhibited cell apoptosis of gastric cancer cells through activation of the PI3K/Akt/mTOR pathway. The PI3K inhibitor, was used to suppress the PI3K/Akt/mTOR pathway, inhibit cell proliferation, promote cell apoptosis, promote caspase-3/-9 and Bax protein expression, and suppress cyclin D1 protein expression of gastric cancer cells through miR-495 inhibition. In conclusion, miR-495 is an important regulator of human gastric cancer cells and may contribute to cell apoptosis through the PI3K/Akt/mTOR/Bax-caspase-3/-9 and cyclin D1 pathway.
引用
收藏
页码:3654 / 3662
页数:9
相关论文
共 26 条
  • [1] Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center
    Allamneni, Chaitanya
    Venkata, Krishna
    Yun, Huifeng
    Xie, Fenglong
    DeLoach, Lindsey
    Malik, Talha A.
    [J]. GASTROENTEROLOGY RESEARCH, 2018, 11 (01) : 41 - 45
  • [2] Canis M, 1997, FERTIL STERIL, V67, P817
  • [3] Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-B and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages
    Cho, Byoung Ok
    Yin, Hong Hua
    Park, Sang Hyun
    Byun, Eui Baek
    Ha, Hun Yong
    Jang, Seon Il
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2016, 80 (08) : 1520 - 1530
  • [4] Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling
    Eissa, Nour
    Hussein, Hayam
    Kermarrec, Laetitia
    Elgazzar, Omar
    Metz-Boutigue, Marie-Helene
    Bernstein, Charles N.
    Ghia, Jean-Eric
    [J]. BIOCHEMICAL PHARMACOLOGY, 2017, 145 : 102 - 113
  • [5] MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis
    Eun, Jung Woo
    Kim, Hyung Seok
    Shen, Qingyu
    Yang, Hee Doo
    Kim, Sang Yean
    Yoon, Jung Hwan
    Park, Won Sang
    Lee, Jung Young
    Nam, Suk Woo
    [J]. JOURNAL OF PATHOLOGY, 2018, 244 (01) : 107 - 119
  • [6] Topological virtual screening: a way to find new compounds active in ulcerative colitis by inhibiting NF-κB
    Galvez-Llompart, Maria
    Recio, Maria C.
    Garcia-Domenech, Ramon
    [J]. MOLECULAR DIVERSITY, 2011, 15 (04) : 917 - 926
  • [7] Protective, effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice
    Gu, Peiqing
    Zhu, Lei
    Liu, Yajun
    Zhang, Lu
    Liu, Junlou
    Shen, Hong
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 50 : 152 - 160
  • [8] A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients
    Hua, Fei
    Ribbing, Jakob
    Reinisch, Walter
    Cataldi, Fabio
    Martin, Steven
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (01) : 101 - 109
  • [9] Kim GD, 2017, J CANCER PREV, V22, P219, DOI 10.15430/JCP.2017.22.4.219
  • [10] Flavonoid myricetin inhibits TNF-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-κB pathways in human keratinocytes
    Lee, Da Hee
    Lee, Chung Soo
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 784 : 164 - 172